MedPath

Comparison of drugs, Fluvoxamine ans Sertraline in patients with OCD in terms of efficacy and effect on neuro-psychological functions.

Not Applicable
Conditions
Health Condition 1: F42- Obsessive-compulsive disorder
Registration Number
CTRI/2020/01/022890
Lead Sponsor
Government Medical College and Hospital Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Diagnosis of OCD as per Diagnostic and Statistical Manual of Mental Disorders-5

2. Treatment-naïve patients

3. Those consenting to participate

4. Age group of 18-55 years

5. Any gender

Exclusion Criteria

1. Depression, anxiety or any other psychiatric illness of diagnosable severity

2. Co-morbid intellectual disability

3. Co-morbid neurological disorder, organic brain syndrome, dementia, or epilepsy

4. Co-morbid substance dependence except caffeine and nicotine

5. Subjects with high, active suicidal risk

6. Subjects with severe medical, surgical or any other condition in which these medications are contraindicated

7. Pregnant and lactating females

8. Subjects who received ECT anytime during preceding three months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To study severity of illness, neuropsychological functions and quality of life in patients with obsessive compulsive disorder. <br/ ><br>2. To study the effect of fluvoxamine and sertraline on severity of illness, neuropsychological functions and quality of life in patients with obsessive compulsive disorder. <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1. To study the association of socio demographic and clinical variables with severity of illness, neuropsychological functions and quality of life in patients with obsessive compulsive disorder. <br/ ><br>2. To compare effects of fluvoxamine and sertraline on above cited parameters. <br/ ><br>Timepoint: Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks
© Copyright 2025. All Rights Reserved by MedPath